- 专利标题： E1E2 HCV VACCINES AND METHODS OF USE
-
申请号： US14783699申请日： 2014-05-15
-
公开(公告)号： US20210145963A9公开(公告)日： 2021-05-20
- 发明人: Michael Houghton , Darren Hockman , John L. Law , Michael Logan , D. Lorne Tyrrell
- 申请人： THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- 申请人地址： CA Edmonton
- 专利权人： THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- 当前专利权人： THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
- 当前专利权人地址： CA Edmonton
- 国际申请： PCT/IB2014/001972 WO 20140515
- 主分类号： A61K39/29
- IPC分类号： A61K39/29
摘要：
The present disclosure provides immunogenic compositions comprising HCV E1, E2, or E1/E2 polypeptides from two or more different HCV genotypes. The present disclosure provides immunogenic compositions comprising HCV E2 or E1/E2 polypeptides from two or more different HCV genotypes. The immunogenic compositions are useful in carrying out methods of inducing an immune response to HCV. The present disclosure further provides methods of stimulating an immune response to HCV in an individual.
公开/授权文献
- US20160067332A1 E1E2 HCV VACCINES AND METHODS OF USE 公开/授权日：2016-03-10
信息查询
